Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Austria Health Focus.
Editas Medicine Announces First Quarter 2025 Results and Business Updates
GlobeNewswire, Inc.
·
May 12, 2025
Company to share in vivo preclinical data demonstrating the successful use of targeted lipid nanoparticles to deliver HBG1/2 promoter editing cargo to hematopoietic stem and progenitor cells (HSPCs) at ASGCT this week Company will also share in...
BlueGrace Energy Bolivia and PH PLUS Take the Grid with Emmo Fittipaldi as 2025 EuroCup-3 Debuts in Austria
EIN Presswire
·
May 16, 2025
Race Car and Suit Now Feature Brand Logos as Legendary Fittipaldi Name Powers the Next Generation of Motorsport and Sustainability. LONDON, GREATER LONDON, UNITED KINGDOM, May 16, 2025 /EINPresswire.com/ -- With the 2025 EuroCup-3 season roaring...
CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3
GlobeNewswire, Inc.
·
May 6, 2025
-Initial CTX310™ Phase 1 clinical data demonstrates dose-dependent decreases in triglycerides (TG) and low-density lipoprotein (LDL), with peak reduction of up to 82% in TG and up to 81% in LDL, with a well-tolerated safety profile; presentation...
Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial
GlobeNewswire, Inc.
·
May 6, 2025
Egham, UK – 6th May 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Duncan Ferguson as Vice...
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight
GlobeNewswire, Inc.
·
May 1, 2025
New York, USA, May 01, 2025 (GLOBE NEWSWIRE) -- Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight The molecular diagnostics market is experiencing significant...
Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland
GlobeNewswire, Inc.
·
May 5, 2025
“CORI on Tour” will highlight the latest advancements in robotics-assisted surgery for hip and knee joint replacement Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a months-long roadshow across central...
Newborn Eye Imaging Systems Market Size Worth USD 3.04 Bn by 2034, Boosted by Advances in Pediatric Ophthalmology and Early Retinal Disease Detection
GlobeNewswire, Inc.
·
April 29, 2025
Ottawa, April 29, 2025 (GLOBE NEWSWIRE) -- The global newborn eye imaging systems market size was valued at USD 1.79 billion in 2024 and is forecasted to rise from USD 1.91 billion in 2025 to USD 3.04 billion by 2034. The market is expected to...
Advancing Healthcare Information Sharing with Computable Consent
GlobeNewswire, Inc.
·
April 24, 2025
VIENNA, Va., April 24, 2025 (GLOBE NEWSWIRE) -- Today, The Sequoia Project, a trusted advocate to advance health information sharing, published the final Moving Toward Computable Consent: A Landscape Review. Authored by the industry and government...
Nourix Sverige Bluff (UPDATED Nourix Avis 2025) Matas Pris en Pharmacie, Trustpilot Recensioner, UK Reviews, Danmark & France Official Website
GlobeNewswire, Inc.
·
April 22, 2025
AMSTERDAM, April 22, 2025 (GLOBE NEWSWIRE) -- Nourix Avis - Effective and healthy weight loss is a typical struggle in an environment where well-being and health are of utmost importance. A lot of people are always searching for the next great...
Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases
GlobeNewswire, Inc.
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS)...
FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Suspends Biologics License: FDA Safety Communication
U.S. Food and Drug Administration
·
August 25, 2025
AUDIENCE: Patient, Health Care Professional, Pharmacy, Cardiology, Neurology, Internal Medicine, Family Practice, Travel Clinics UPDATE: On August 22, 2025, the US FDA’s Center for Biologics Evaluation and Research (CBER) has suspended the...
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
GlobeNewswire, Inc.
·
April 10, 2025
ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high...
Medical Spa Market Reaches New Heights, Expected to Hit $82.5 Billion by 2034, Driven by Anti-Aging and Wellness Trends | Latest Report by Transparency Market Research
GlobeNewswire, Inc.
·
February 7, 2025
Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 07, 2025 (GLOBE NEWSWIRE) -- The global medical spa market (mercato delle terme mediche) has reached a valuation of US$18.6 billion in 2023 and is anticipated to grow at a CAGR of...
Gain Therapeutics Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287 at AD/PD 2025 and Provides Enrollment Update
GlobeNewswire, Inc.
·
April 10, 2025
GT-02287 oral presentation demonstrates new evidence of disease-modifying capacity in GBA1 and idiopathic Parkinson’s disease models Enrollment update provided for Phase 1b study Phase 1b study ongoing to assess safety, tolerability,...
Okeiro raises €10 Million to accelerate development of its Precision Medicine platform for Transplantation and Chronic Diseases
GlobeNewswire, Inc.
·
April 10, 2025
Okeiro raises €10 Million to accelerate development of its Precision Medicine platform for Transplantation and Chronic Diseases Paris, April 10, 2025 – Okeiro, a company specializing in precision medicine for transplantation and advanced chronic...
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025
GlobeNewswire, Inc.
·
April 10, 2025
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company developing specialty therapies for community care and public health challenges, today announced that data from several new studies of...
NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
GlobeNewswire, Inc.
·
April 7, 2025
Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells per treatment. After 12 months of treatment, both patients who completed 17 doses improved from moderate to mild AD within...
'The World of Hans Zimmer - A New Dimension' Delivers Electrifying Start to North American Tour
EIN Presswire
·
September 9, 2025
A Full Live Orchestra Performing Zimmer’s Music, Including “The Dark Knight,” “Interstellar,” and “Inception,” Sweeps Opening Night Audience Off Its Feet LOS ANGELES, CA, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- The World of Hans...
SCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
GlobeNewswire, Inc.
·
April 8, 2025
JERSEY CITY, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation...
Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals
GlobeNewswire, Inc.
·
April 11, 2025
www.inbiome.com Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID for Critical Cases Molecular Fingerprinting: AI-Powered ‘DNA...